584 Long-term low dose treatment with pegylated interferon α-2b leads to a significant reduction in fibrosis in chronic hepatitis C nonresponder patients
S. Kaiser, H. Hass, B. Lutze, M. GregorVolume:
44
Year:
2006
Language:
english
DOI:
10.1016/s0168-8278(06)80584-2
File:
PDF, 123 KB
english, 2006